Skip to content
Screener

Sanara MedTech Inc. SMTI Q1 2026 earnings

Reported May 11, 2026 · Before market open

Revenue$27.8MBeat by $998.5K
EPS$0.04Beat by $0.17
Revenue estimate$26.8M
EPS estimate-$0.13

Next report

Nov 11, 2026 (in a month)
Revenue estimate$29.7M
EPS estimate$0.06

Financials

Q1 2026

Income statement

See full
Revenue$27.8M+18.6%
Gross profit$25.9M+19.8%
Operating income$2.6M+221%
Net income$459.0K+113%
EPS (diluted)$0.05+112%

Balance sheet

See full
Cash & equivalents$13.6M-34.3%
Total debt$48.4M+8.2%
Total equity$7.0M-80.8%
Total assets$69.3M-28.1%

Cash flow

See full
Operating cash flow-$2.5M-23.3%
CapEx$43.8K-97.5%
Free cash flow-$2.5M+32.6%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$157.49M-42.7%
Enterprise value$192.26M-35.7%
P/S1.5×-1.5×

Profitability

See full
Gross margin92.9%+1.7pp
Operating margin8.5%+7.4pp
Net margin-31.2%-93.3pp

Returns & leverage

See full
Return on equity-153.7%-199pp
Debt / equity6.9×+5.7×
Current ratio2.3×-0.5×

Segments

By product

See full
Soft Tissue Repair Products$24.9M+21.5%
Bone Fusion Products$2.9M-1.6%

FAQ

When did Sanara MedTech Inc. report Q1 2026 earnings?
Sanara MedTech Inc. (SMTI) reported Q1 2026 earnings on May 11, 2026 before market open.
What were Sanara MedTech Inc.'s Q1 2026 revenue and EPS?
Sanara MedTech Inc. reported revenue of $27.8M and eps of $0.04 for Q1 2026.
Did Sanara MedTech Inc. beat estimates in Q1 2026?
Revenue beat the consensus estimate of $26.8M by $998.5K. EPS beat the consensus estimate of $-0.13 by $0.17.
How did Sanara MedTech Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 18.6% from $23.4M a year earlier.
Where can I find Sanara MedTech Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-022291) and the 10-Q periodic report (0001493152-26-022479) directly on SEC EDGAR. The filing index links above go to sec.gov.